Gut fuel utilisation has several unique features. Arterial and luminal
fuels provide nutrition for the enterocyte, the former being of more
importance. This factor, and the heterogeneity of cell types within th
e gut makes it difficult to define its fuel utilisation. Metabolic con
trol logic suggests that modulation of the maximal activity of any pat
hway resides in those enzymes that operate in vivo at rates far below
their maximal capacity and that catalyse non-equilibrium reactions. On
this basis, although enterocyte hexokinase activity is much higher th
an in other 'glycolytic' cells (for example, brain), potentially high
rates of glucose utilisation are modulated by substrate cycling of glu
cose 6-phosphate back to glucose through glucose 6-phosphatase. Glutam
ine metabolism proceeds by glutaminase to produce glutamate, which may
then be transaminated (aspartate-aminotransferase and alanine-amino t
ransferase) to produce alpha-ketoglutarate, alanine, and aspartate. Th
e end products of glutamine metabolism by incubated gut preparations i
n vitro (mainly alanine), suggests that enterocytes, not immune cells,
are responsible for most gut glutamine metabolism. High flux rates of
glucose and glutamine metabolism in the enterocyte may result from th
e need for de novo synthesis of purines and pyrimidines and ribose sug
ars for nucleic acid synthesis. Sepsis reduces rates of glucose and gl
utamine metabolism, perhaps to preserve the increased consumption of t
hese fuels by activated lymphocytes and macrophages in the gut wall.